Kcm Investment Advisors LLC Biogen Inc. Transaction History

Kcm Investment Advisors LLC

  • $2.76 Billion
  • Q2 2024

A detailed history of Kcm Investment Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Kcm Investment Advisors LLC holds 2,944 shares of BIIB stock, worth $511,637. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,944
Previous 2,953 0.3%
Holding current value
$511,637
Previous $636,000 7.23%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
SELL
$190.52 - $236.72 $1,714 - $2,130
-9 Reduced 0.3%
2,944 $682,000
Q1 2024

May 07, 2024
BUY
$212.02 - $267.71 $10,176 - $12,850
48 Added 1.65%
2,953 $636,000
Q4 2023

Feb 13, 2024
SELL
$222.59 - $267.94 $3,116 - $3,751
-14 Reduced 0.48%
2,905 $751,000
Q1 2023

May 09, 2023
BUY
$256.56 - $292.34 $748,898 - $853,340
2,919 New
2,919 $811,000
Q4 2022

Jan 31, 2023
SELL
$252.44 - $306.72 $1,009 - $1,226
-4 Reduced 0.14%
2,919 $808,000
Q2 2022

Aug 15, 2022
SELL
$187.54 - $223.02 $187 - $223
-1 Reduced 0.03%
2,923 $596,000
Q1 2022

May 13, 2022
SELL
$193.77 - $244.14 $45,729 - $57,617
-236 Reduced 7.47%
2,924 $616,000
Q3 2021

Nov 12, 2021
BUY
$282.99 - $369.05 $3,112 - $4,059
11 Added 0.35%
3,160 $894,000
Q2 2021

Aug 12, 2021
SELL
$259.0 - $414.71 $99,456 - $159,248
-384 Reduced 10.87%
3,149 $1.09 Million
Q1 2021

May 13, 2021
SELL
$242.95 - $284.63 $43,002 - $50,379
-177 Reduced 4.77%
3,533 $988,000
Q4 2020

Feb 19, 2021
SELL
$236.26 - $355.63 $68,042 - $102,421
-288 Reduced 7.2%
3,710 $908,000
Q3 2020

Nov 16, 2020
SELL
$264.77 - $305.71 $53,483 - $61,753
-202 Reduced 4.81%
3,998 $1.13 Million
Q2 2020

Aug 14, 2020
BUY
$258.66 - $342.55 $12,157 - $16,099
47 Added 1.13%
4,200 $1.12 Million
Q1 2020

Apr 27, 2020
BUY
$268.85 - $341.04 $1.12 Million - $1.42 Million
4,153 New
4,153 $1.31 Million
Q4 2019

Feb 18, 2020
SELL
$220.06 - $304.07 $4,401 - $6,081
-20 Reduced 0.49%
4,049 $1.2 Million
Q2 2019

Aug 14, 2019
SELL
$219.29 - $241.72 $2,192 - $2,417
-10 Reduced 0.25%
4,069 $952,000
Q1 2019

May 16, 2019
SELL
$216.71 - $338.96 $888,294 - $1.39 Million
-4,099 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$257.52 - $306.91 $37,340 - $44,501
145 Added 3.67%
4,099 $1.19 Million
Q1 2018

May 09, 2018
SELL
$260.13 - $367.91 $105,352 - $149,003
-405 Reduced 9.29%
3,954 $1.08 Million
Q4 2017

Feb 22, 2018
SELL
$307.64 - $344.58 $34,148 - $38,248
-111 Reduced 2.48%
4,359 $1.39 Million
Q3 2017

Nov 13, 2017
BUY
$281.15 - $329.69 $1.26 Million - $1.47 Million
4,470
4,470 $1.4 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Kcm Investment Advisors LLC Portfolio

Follow Kcm Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email